Error | Effect on tumor SUV |
---|---|
Paravenous 18F-FDG injection, residual activity in syringe | Incorrectly low SUV because area under plasma time–activity curve is smaller |
No decay correction of injected activity | Incorrectly low SUV |
Incorrect cross-calibration of scanner and dose calibrator | Incorrectly low or high SUV, depending on error of calibration factor |
Variable uptake period (time between injection and imaging) | Higher SUV with longer uptake period |